Order Article Reprints

Hu S-Y, Lin T-H, Chen C-Y, He Y-H, Huang W-C, Hsieh C-Y, Chen Y-H, Chang W-C. Stephania tetrandra and Its Active Compound Coclaurine Sensitize NSCLC Cells to Cisplatin through EFHD2 Inhibition. Pharmaceuticals. 2024; 17(10):1356. https://doi.org/10.3390/ph17101356

Hu, Shu-Yu, Tsai-Hui Lin, Chung-Yu Chen, Yu-Hao He, Wei-Chien Huang, Ching-Yun Hsieh, Ya-Huey Chen, and Wei-Chao Chang. 2024. "Stephania tetrandra and Its Active Compound Coclaurine Sensitize NSCLC Cells to Cisplatin through EFHD2 Inhibition" Pharmaceuticals 17, no. 10: 1356. https://doi.org/10.3390/ph17101356

Hu, S.-Y., Lin, T.-H., Chen, C.-Y., He, Y.-H., Huang, W.-C., Hsieh, C.-Y., Chen, Y.-H., & Chang, W.-C. (2024). Stephania tetrandra and Its Active Compound Coclaurine Sensitize NSCLC Cells to Cisplatin through EFHD2 Inhibition. Pharmaceuticals, 17(10), 1356. https://doi.org/10.3390/ph17101356